NEWS

June 10, 2013

Renewal: Message from President

June 11, 2012

Renewal:Message from President

April 2, 2012

Eisai and Minophagen Pharmaceutical Conclude License Agreement Concerning the Development and Commercialization of Cutaneous T-Cell Lymphoma Treatment Bexarotene in Asia, Oceania, the Middle East and Eastern Europe, etc.

July 4, 2011

Renewal:Message from President

May 30, 2011

Announcement of headquarters relocation

March 30, 2011

Eisai and Minophagen Pharmaceutical Conclude Japan License Agreement For Cutaneous T-Cell Lymphoma Treatment Bexarotene

BackNumber
Get Adobe Flash Player

You need Adobe Flash Player to view the web pages.
Adobe Flash Player is freeware; you can download it from the download site.

Get Adobe Reader

You need Adobe Reader to view and print the web pages.
Adobe Reader is freeware; you can download it from the download site.